Dublin, Feb. 29, 2016 (GLOBE NEWSWIRE) — Research and Markets (http://www.researchandmarkets.com/research/xrrhhw/hospitalacquired) has announced the addition of the “Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)” report to their offering.
Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection.
This Hospital-Acquired Infections report takes a solid look at
- Hospital-Acquired Infection Statistics
- Device Sterilization Market
- Hospital Area Disinfection Market
- HAI Testing Market
- Treatment Market
- Market Segmentation by Healthcare Location: Hospital, Nursing Home, Other
- Market Segmentation by Geographic Location: US, EU, Asia, Other
The following companies are among those discussed in the report:
- Advanced Sterilization Products
- Becton Dickinson
- Belimed AG
- bioMerieux
- Cantel
- Cepheid
- Getinge
- Merck & Co.
- Nordion
- Pfizer
- Roche
- Sakura Seiki
- Steris
- TSO3
Key Topics Covered:
EXECUTIVE SUMMARY
Overview
The Nosocomial Infection
Market Scope
Research Methodology
Industry Challenges
Total Size and Growth of the Market
Issues and Trends Affecting Market
Leading Competitors
INTRODUCTION AND INDUSTRY TRENDS
Overview
Introduction to Pathogens
Classification of Antibacterial Organisms
Common Hospital (nosocomial) Infections
Description of Infections
Acinetobacter Baumannii
Clostridium Difficile
Gastroenteritis
Hospital-Acquired Pneumonia (HAP)
Pseudomonas Aeruginosa
Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus
Stenotrophomonas Maltophilia
Tuberculosis
Urinary Tract Infections
Vancomycin-Resistant Enterococcus
Ventilator-Associated Pneumonia (VAP)
Patient Risk Factors
General Populations at Risk for Infection
World Demographics
Assessing the Problem: Nosocomial Infection Statistics
Infection Risk Assessments by Hospital Department
Burn Units
Intensive Care Units
Emergency Departments
Hospital Length of Stay
Increased Hospital Length of Stay for HAIs
Extended Stay Environments
International Trends in Nursing Facilities
Economic Trends
Comparison between Healthcare Spending and Real Health Outcomes
U.S. Government’s National Plan to Prevent Healthcare Associated Infections (HAIs)43
Steering Committee
Affordable Care Act (ACA) Funding
Government Funding for HAI Prevention Infrastructure Activities
The Department of Health and Human Services: 2016 Budget Highlights
National Healthcare Safety Network
Hospital infection Surveillance Process
Screening Hospitalized Patients
Pharmaceutical Manufacturer and Marketer Trends
Trends in Partnerships and Alliances
Developers Trends
INFECTION PREVENTION
Overview
Methods of Transmission
Airborne
Contact
Droplet
Vehicle
High-Risk Facilities or Departments
Technology Overview
Potential Use of Copper for Reducing Infections
Wide Area Disinfection Methods
Software for Infection Detection and Control
Antiseptic-Coated Catheters
UV-C Reflective Coatings
Specialized Disinfection/Sterilization Systems
Sterilization vs. Disinfection
Sterilization
Disinfection
Equipment and Solutions
Heat/Steam Sterilization
Product Examples
Chemical Sterilization
Sterilants
Product Examples
Mid-Level Disinfectants
Suppliers
Radiation Sterilization
Product Examples
Sterilization and Disinfection Verification Systems
Market Overview
Hospital infection Prevention Market by Geographical Region
Competitive Analysis
INFECTION TESTING
Overview
Drug-Resistance/Susceptibility Testing
Genotypic Methods
DNA Sequencing
Solid-phase Hybridization Techniques
Microarrays
Real-time Polymerase Chain Reaction Techniques
Phenotypic Methods
Phage-based Assays
Colorimetric Methods
The Nitrate Reductase Assay
Specific Serious Hospital infection Testing
Acinetobacter Baumannii
Clostridium Difficile
Product Examples
Hospital-Acquired Pneumonia
Pseudomonas Aeruginosa
Staphylococcus Aureus
Methicillin-resistant Staphylococcus Aureus (MRSA)
Vancomycin-Intermediate/Resistant Staphylococcus Aureus (VISA/VRSA)
Product Examples
Tuberculosis
Product Examples
Urinary Tract Infections
Vancomycin-resistant Enterococcus
Ventilator-Associated Pneumonia
New Developments
Market Overview
Total Market Size and Forecast
Hospital infection Testing Market by Geographical Region
Competitive Analysis
INFECTION TREATMENT
Overview
Principles of Anti-bacterial Therapy
Infecting Organism
Antibiotic Sensitivity Testing
Site of Infection
Host Defenses and Organ Function
Antibiotic Pharmacokinetics
Monitoring Therapy
Classifications of Antibacterial Products
Carbapenems
Cephalosporins
Macrolides
Penicillins
Quinolones
Sulfonamides
Tetracyclines
Infections and Drug Resistance
Easing Approvals of Antibiotics
Causes of Drug Resistance
Antibiotic Abuse
Antibiotic Use in Agriculture
Drug Resistance in Select Populations
Children
The Elderly
Compromised Individuals
Measures for Reducing Resistance
Testing for the Selection of Anti-bacterial Therapy
Monitoring Therapy
Treatment Guidelines
Clostridium Difficile
Gastroenteritis
Hospital-Acquired Pneumonia
Ventilator-associated Pneumonia
Pseudomonas Aeruginosa
Staphylococcus Aureus
Stenotrophomonas maltophilia
Tuberculosis
Urinary Tract Infections
Leading Products
New Developments
Development Incentives
Total Market Size and Forecast
Hospital infection Treatment Market by Geographical Region
Competitive Analysis
MARKET OPPORTUNITIES FOR HOSPITAL INFECTION CONTROL
Market Considerations
Market Overview
Healthcare-Acquired Infection Distribution by Setting
The Global Market for Hospital infection Control Estimated Market Share by Facility Setting, 2015
The Global Market for Hospital infection Control Estimated Market Share by Hospital Department,2015
Hospital infection Control Market by Geographical Region
Developed and Emerging Market Analysis
COMPANY PROFILES
Becton, Dickinson and Company
Belimed
bioMerieux
Cantel
Cepheid
Getinge Group
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
Steris
Tso3
For more information visit http://www.researchandmarkets.com/research/xrrhhw/hospitalacquired
CONTACT:
CONTACT: Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Disease Testing, Disinfectants
